Dr. Bukavina and Dr. Psutka share take-homes from kidney cancer epidemiology paper

Author(s):

“We need to continue to push the field forward, and the way we do that is to evaluate the risk factors and to stratify patients based on their risk factors and their genetic components,” says Laura Bukavina, MD, MPH.

In this video, Laura Bukavina, MD, MPH, and Sarah P. Psutka, MD, MS, discuss the take-home messages from the European Urology study, “Epidemiology of Renal Cell Carcinoma: 2022 Update.” Bukavina is a urologic oncology fellow at Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Psutka is an associate professor of urology at University of Washington Medical Center, Seattle.